大動脈ステントグラフト市場：パイプラインレポート（開発段階、セグメント、地域・国、規制経路、主要企業）

大動脈ステントグラフトは、破裂を防ぐために弱った大動脈を補強するために使用されます。

当レポートでは、大動脈ステントグラフト市場について調査し、製品概要と開発中のパイプライン製品動向、様々な開発段階にある製品の比較分析や進行中の臨床試験に関する情報、参入企業の最近の動向などを提供しています。

目次

第1章 目次

第2章 イントロダクション

• 大動脈ステントグラフトの概要

第3章 開発中の製品

• 大動脈ステントグラフト - 開発段階別パイプライン製品
• 大動脈ステントグラフト - セグメント別パイプライン製品
• 大動脈ステントグラフト - 地域別パイプライン製品
• 大動脈ステントグラフト - 規制経路別パイプライン製品
• 大動脈ステントグラフト - 推定承認日別パイプライン製品
• 大動脈ステントグラフト - 進行中の臨床試験

第4章 大動脈ステントグラフト- 企業が開発中のパイプライン製品

• 大動脈ステントグラフト企業- 開発段階別のパイプライン製品
• 大動脈ステントグラフト- 開発段階別のパイプライン製品

第5章 大動脈ステントグラフト企業と製品概要

• Affluent Medical SASU
• Angiolutions UG
• APT Medical Inc
• Artivion Inc
• Ascyrus Medical LLC
• Beijing Tianzhu Ruichang Medical Technology Co Ltd
• BiFlow Medical Ltd
• BioQ Devices Pty Ltd
• Cook Medical Inc
• Cytograft Tissue Engineering Inc
• Endologix LLC
• Endoluminal Sciences Pty Ltd.
• EndoSpan Ltd
• Evasc Medical Systems Corp
• Hadassah Medical Center
• Hangzhou Endom Medtech Co Ltd
• Intressa Vascular SA
• Johns Hopkins University
• JOTEC GmbH
• Kawasumi Laboratories Inc
• Lifetech Scientific（Shenzhen）Co Ltd
• Lombard Medical Technologies Inc.
• Lombard Medical Technologies Ltd
• Lundquist
• Medtronic Plc
• Merit Medical Systems Inc
• MicroPort Scientific Corp
• PerMed Biomedical Engineering Co Ltd
• Red Vascular Technologies LLC
• Shanghai MicroPort Endovascular MedTech Group Co Ltd
• Sree Chitra Tirunal Institute for Medical Sciences & Technology
• St. Jude Medical LLC
• Terumo Aortic
• Terumo Corp
• The Lundquist Institute
• TriVascular Inc
• University of Arizona
• University of Colorado Denver
• University of Limerick
• University of Nebraska Medical Center
• Venus Medtech Hangzhou Inc
• WL Gore &Associates Inc
• Zylox-Tonbridge Medical Technology Co Ltd

第6章 大動脈ステントグラフト- 最近の開発

第7章 付録

• 調査手法
• GlobalDataについて
• お問合せ
• 免責事項

List of Tables

List of Tables

• Aortic Stent Grafts - Pipeline Products by Stage of Development
• Aortic Stent Grafts - Pipeline Products by Segment
• Aortic Stent Grafts - Pipeline Products by Territory
• Aortic Stent Grafts - Pipeline Products by Regulatory Path
• Aortic Stent

List of Figures

List of Figures

• Aortic Stent Grafts - Pipeline Products by Stage of Development
• Aortic Stent Grafts - Pipeline Products by Segment
• Aortic Stent Grafts - Pipeline Products by Territory
• Aortic Stent Grafts - Pipeline Products by Regulatory Path
• Aortic Stent

Abstract

GlobalData's Medical Devices sector report, "Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Aortic Stent Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Aortic Stent grafts are used to reinforce a weaken aorta to prevent ruptures.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Aortic Stent Grafts under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Aortic Stent Grafts and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Aortic Stent Grafts under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Aortic Stent Grafts Overview

3 Products under Development

• 3.1 Aortic Stent Grafts - Pipeline Products by Stage of Development
• 3.2 Aortic Stent Grafts - Pipeline Products by Segment
• 3.3 Aortic Stent Grafts - Pipeline Products by Territory
• 3.4 Aortic Stent Grafts - Pipeline Products by Regulatory Path
• 3.5 Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
• 3.6 Aortic Stent Grafts - Ongoing Clinical Trials

4 Aortic Stent Grafts - Pipeline Products under Development by Companies

• 4.1 Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
• 4.2 Aortic Stent Grafts - Pipeline Products by Stage of Development

5 Aortic Stent Grafts Companies and Product Overview

• 5.1 Affluent Medical SASU Company Overview
  • 5.1.1 Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Angiolutions UG Company Overview
  • 5.2.1 Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 APT Medical Inc Company Overview
  • 5.3.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 Artivion Inc Company Overview
  • 5.4.1 Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Ascyrus Medical LLC Company Overview
  • 5.5.1 Ascyrus Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Beijing Tianzhu Ruichang Medical Technology Co Ltd Company Overview
  • 5.6.1 Beijing Tianzhu Ruichang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 BiFlow Medical Ltd Company Overview
  • 5.7.1 BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 BioQ Devices Pty Ltd Company Overview
  • 5.8.1 BioQ Devices Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Cook Medical Inc Company Overview
  • 5.9.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Cytograft Tissue Engineering Inc (Inactive) Company Overview
  • 5.10.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Endologix LLC Company Overview
  • 5.11.1 Endologix LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Endoluminal Sciences Pty Ltd. Company Overview
  • 5.12.1 Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 EndoSpan Ltd Company Overview
  • 5.13.1 EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Evasc Medical Systems Corp Company Overview
  • 5.14.1 Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Hadassah Medical Center Company Overview
  • 5.15.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Hangzhou Endonom Medtech Co Ltd Company Overview
  • 5.16.1 Hangzhou Endonom Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 Intressa Vascular SA Company Overview
  • 5.17.1 Intressa Vascular SA Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 Johns Hopkins University Company Overview
  • 5.18.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 JOTEC GmbH Company Overview
  • 5.19.1 JOTEC GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.20 Kawasumi Laboratories Inc Company Overview
  • 5.20.1 Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.21 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
  • 5.21.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.22 Lombard Medical Technologies Inc. Company Overview
  • 5.22.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.23 Lombard Medical Technologies Ltd (Inactive) Company Overview
  • 5.23.1 Lombard Medical Technologies Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.24 Lundquist Company Overview
  • 5.24.1 Lundquist Pipeline Products & Ongoing Clinical Trials Overview
• 5.25 Medtronic Plc Company Overview
  • 5.25.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.26 Merit Medical Systems Inc Company Overview
  • 5.26.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.27 MicroPort Scientific Corp Company Overview
  • 5.27.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.28 PerMed Biomedical Engineering Co Ltd Company Overview
  • 5.28.1 PerMed Biomedical Engineering Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.29 Red Vascular Technologies LLC Company Overview
  • 5.29.1 Red Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.30 Shanghai MicroPort Endovascular MedTech Group Co Ltd Company Overview
  • 5.30.1 Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.31 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
  • 5.31.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
• 5.32 St. Jude Medical LLC Company Overview
  • 5.32.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.33 Terumo Aortic Company Overview
  • 5.33.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview
• 5.34 Terumo Corp Company Overview
  • 5.34.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.35 The Lundquist Institute Company Overview
  • 5.35.1 The Lundquist Institute Pipeline Products & Ongoing Clinical Trials Overview
• 5.36 TriVascular Inc Company Overview
  • 5.36.1 TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.37 University of Arizona Company Overview
  • 5.37.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
• 5.38 University of Colorado Denver Company Overview
  • 5.38.1 University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview
• 5.39 University of Limerick Company Overview
  • 5.39.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview
• 5.40 University of Nebraska Medical Center Company Overview
  • 5.40.1 University of Nebraska Medical Center Pipeline Products & Ongoing Clinical Trials Overview
• 5.41 Venus Medtech Hangzhou Inc Company Overview
  • 5.41.1 Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.42 W. L. Gore & Associates Inc Company Overview
  • 5.42.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.43 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
  • 5.43.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Aortic Stent Grafts- Recent Developments

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer